Hormone Therapy News

PHILADELPHIA — Although hormone therapy has not been shown to decrease established depressive symptoms during menopause, euthymic perimenopausal women may be protected from developing depressive symptoms with transdermal estradiol treatment, according to a presenter at the Annual Meeting of the North American Menopause Society.

PHILADELPHIA — Hormone therapy for menopausal women is one of the best examples of precision medicine in clinical practice and remains the most effective first-line treatment for the common symptoms of menopause, according to a speaker here.

PHILADELPHIA — Combination estrogen and progestin hormone therapy can serve as a “necessary evil” for endometrial protection, but its use comes with caveats for some menopausal women, according to a speaker here.

PHILADELPHIA — In this video exclusive, Sheryl A. Kingsberg, PhD, president-elect of the North American Society, discusses data showing flibanserin may be safe and effective for treatment of hypoactive sexual desire disorder in postmenopausal women.

PHILADELPHIA — U.S. women attending a community health fair expressed skepticism about hormone therapy and reported that they preferred to treat hot flashes and other bothersome menopause symptoms with alternative options, according to a study presented at the Annual Meeting of the North American Menopause Society.

PHILADELPHIA — In this video exclusive, JoAnn V. Pinkerton, MD, NCMP, professor of obstetrics and gynecology at the University of Virginia and executive director of The North American Menopause Society reviews the NAMS 2017 Hormone Therapy Position Statement. For women aged younger than 60 years or within 10 years of menopause, hormone therapy is safe and effective for relieving hot flushes and night sweats, improving sleep and preventing osteoporosis and fractures, according to the statement.

PHILADELPHIA — A decade after the Women’s Health Initiative clinical trials, misperceptions regarding hormone therapy and gaps in knowledge prevent women from accessing treatment for menopausal symptoms, according to a study presented at the Annual Meeting of the North American Menopause Society.

The changing role of technology and its impact on menopause health will serve as the theme for this year’s North American Menopause Society Annual Meeting, with programming exploring topics ranging from musculoskeletal health and advances in breast imaging to migraines, mood disorders and hormone therapy.

Women with childhood-onset combined pituitary hormone deficiencies have successful pregnancies when treated with adequate hormone replacement before ovarian stimulation, according to findings published in the Journal of the Endocrine Society.

Data from two systematic reviews and meta-analyses recently published in The Journal of Clinical Endocrinology & Metabolism examined the effects of sex steroids on cardiovascular outcomes and bone health in transgender individuals and revealed no increased risks for low bone mineral density, fracture or cardiovascular outcomes with the therapy.